Differential responses from seven mammalian cell lines to the treatments of detoxifying enzyme inducers

被引:79
作者
Jiang, ZQ [1 ]
Chen, C [1 ]
Yang, B [1 ]
Hebbar, V [1 ]
Kong, ANT [1 ]
机构
[1] Univ Illinois, Coll Pharm, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA
关键词
Hepalclc7; HepG2; MCF7; MDA-MB-231; LNCaP; HeLa; HT-29; tBHQ; beta-NF; sulforaphane; GST; QR; AR; GR;
D O I
10.1016/S0024-3205(03)00101-2
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cell-based models have been used extensively in screening novel bioactive chemical entities. In this study, seven well-established mammalian cell lines, which have different origins, were utilized to compare their responses to the treatments of three detoxifying enzyme inducers, tert-butylhydroquinone (tBHQ), beta-naphthoflavone (beta-NF), and sulforaphane (SUL), which are potential chemopreventive compounds. The enzymatic activities of glutathione s-transferase (GST), NAD(P)H:quinone oxidoreductase (QR), aldehyde reductase (AR), and glutathione reductase (GR) were measured by kinetics methods using UV-Vis spectroscopy, and analyzed statistically by Student's t-test. Among these mammalian cell lines, the mouse hepatoma Hepa1c1c7 cells were the most robust and sensitive cells, which had higher basal as well as upregulated enzymatic activities. In human cell lines, the prostate LNCaP and hepatic HepG2 cells were also very responsive to the inducers. The results suggested that different cell lines responded differently to individual detoxifying gene inducer, and the selection of appropriate cell line is important for screening potential chemopreventive agents. (C) 2003 Published by Elsevier Science Inc.
引用
收藏
页码:2243 / 2253
页数:11
相关论文
共 25 条
[1]   INDUCTION OF PHASE-I AND PHASE-II DRUG-METABOLIZING ENZYME MESSENGER-RNA, PROTEIN, AND ACTIVITY BY BHA, ETHOXYQUIN, AND OLTIPRAZ [J].
BUETLER, TM ;
GALLAGHER, EP ;
WANG, CH ;
STAHL, DL ;
HAYES, JD ;
EATON, DL .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 135 (01) :45-57
[2]   Application of DNA Microarrays in pharmacogenomics and toxicogenomics [J].
Chin, KV ;
Kong, ANT .
PHARMACEUTICAL RESEARCH, 2002, 19 (12) :1773-1778
[3]   Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate [J].
Chung, FL ;
Conaway, CC ;
Rao, CV ;
Reddy, BS .
CARCINOGENESIS, 2000, 21 (12) :2287-2291
[4]   Decomposition rates of isothiocyanate conjugates determine their activity as inhibitors of cytochrome P450 enzymes [J].
Conaway, CC ;
Krzeminski, J ;
Amin, S ;
Chung, FL .
CHEMICAL RESEARCH IN TOXICOLOGY, 2001, 14 (09) :1170-1176
[5]   EFFECT OF PHENETHYL ISOTHIOCYANATE ON THE METABOLISM OF THE TOBACCO-SPECIFIC NITROSAMINE 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE BY CULTURED RAT LUNG-TISSUE [J].
DOERROROURKE, K ;
TRUSHIN, N ;
HECHT, SS ;
STONER, GD .
CARCINOGENESIS, 1991, 12 (06) :1029-1034
[6]   INHIBITORY EFFECT OF (-)-EPIGALLOCATECHIN GALLATE ON CARCINOGENESIS WITH N-ETHYL-N'-NITRO-N-NITROSOGUANIDINE IN MOUSE DUODENUM [J].
FUJITA, Y ;
YAMANE, T ;
TANAKA, M ;
KUWATA, K ;
OKUZUMI, J ;
TAKAHASHI, T ;
FUJIKI, H ;
OKUDA, T .
JAPANESE JOURNAL OF CANCER RESEARCH, 1989, 80 (06) :503-505
[7]   INHIBITION OF AFLATOXIN B-1-HEPATOCARCINOGENESIS IN RATS BY BETA-NAPHTHOFLAVONE [J].
GURTOO, HL ;
KOSER, PL ;
BANSAL, SK ;
FOX, HW ;
SHARMA, SD ;
MULHERN, AI ;
PAVELIC, ZP .
CARCINOGENESIS, 1985, 6 (05) :675-678
[8]  
HECHT SS, 1995, J CELL BIOCHEM, P195
[9]   Chemoprevention of heterocyclic amine-induced carcinogenesis by phenolic compounds in rats [J].
Hirose, M ;
Takahashi, S ;
Ogawa, K ;
Futakuchi, M ;
Shirai, T ;
Shibutani, M ;
Uneyama, C ;
Toyoda, K ;
Iwata, H .
CANCER LETTERS, 1999, 143 (02) :173-178
[10]   Progress in cancer chemoprevention: Development of diet-derived chemopreventive agents [J].
Kelloff, GJ ;
Crowell, JA ;
Steele, VE ;
Lubet, RA ;
Malone, WA ;
Boone, CW ;
Kopelovich, L ;
Hawk, ET ;
Lieberman, R ;
Lawrence, JA ;
Ali, I ;
Viner, JL ;
Sigman, CC .
JOURNAL OF NUTRITION, 2000, 130 (02) :467S-471S